BridgeMD
New treatment option for Myocardial Infarction
Official title Vegetarian Diet and Innate Immunity in Patients With Myocardial Infarction and in Healthy Volunteers (FRESH-MI Study)
ClinicalTrials.gov ID: NCT06209723
What this study is testing
- What it's testing
- The goal of this clinical trial is to assess the effect of a vegetarian diet on innate immunity of patients with a recent acute myocardial infarction and healthy participants. Also, we will assess the willingness to adapt a more vegetarian eating habit.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- for patients:
- Acute myocardial infarction (STEMI/NSTEMI) with a clear culprit lesion on angiography and successful primary percutaneous coronary intervention (PCI)...
- Body mass index between 18.5 and 35 kg/m2
- Written informed consent for healthy volunteers (life partners / souses)
- Body mass index between 18.5 and 35 kg/m2
You likely can't join if
- for patients and healthy volunteers:
- Already on a vegetarian or vegan diet
- Previous myocardial infarction
- Diabetes Mellitus
- Medical history of any disease associated with immune deficiency (either congenital or acquired, including chemotherapy, chronic steroid use, organ...
- Use of immunomodulatory drugs
See the full eligibility criteria
- for patients:
- Acute myocardial infarction (STEMI/NSTEMI) with a clear culprit lesion on angiography and successful primary percutaneous coronary intervention (PCI) \<1 week before randomisation
- Body mass index between 18.5 and 35 kg/m2
- Written informed consent for healthy volunteers (life partners / souses)
- Body mass index between 18.5 and 35 kg/m2
- Written informed consent
- for patients and healthy volunteers:
- Already on a vegetarian or vegan diet
- Previous myocardial infarction
- Diabetes Mellitus
- Medical history of any disease associated with immune deficiency (either congenital or acquired, including chemotherapy, chronic steroid use, organ transplant)
- Use of immunomodulatory drugs
- Vaccination less than one month before start of intervention
- Clinically significant infections within 1 months prior to start of intervention (defined as fever \>38.5 degrees Celsius)
- Active malignant haematological disease
- Known eating disorder (e.g., Anorexia nervosa, Bulimia nervosa) Exclusion Criteria for healthy volunteers \- Use of lipid lowering therapy
The study team makes the final eligibility decision.
Where it's taking place
- Nijmegen, Netherlands
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nijmegen, Netherlands. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.